title: Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.
authors.affiliation: a Department of Pediatrics and Center for Biomedical Ethics and Society , Vanderbilt University School of Medicine , Nashville , TN , USA.|b The CITI Japan Project , Shinshu University , Matsumoto , Nagano , Japan.
authors.forename: Iekuni
authors.initials: I
authors.lastname: Ichikawa
authors.affiliation: a Department of Pediatrics and Center for Biomedical Ethics and Society , Vanderbilt University School of Medicine , Nashville , TN , USA.
authors.forename: Ellen Wright
authors.initials: EW
authors.lastname: Clayton
mesh_terms: D001291:Attitude of Health Personnel; D016265:Conflict of Interest; D004345:Drug Industry / Q000941:ethics*; D005260:Female; D037921:Gift Giving / Q000941:ethics*; D006801:Humans; D007564:Japan; D008297:Male; D040541:Marketing; D010818:Practice Patterns, Physicians' / Q000941:ethics*; D012108:Research Personnel / Q000941:ethics*
references.citation: JAMA. 1999 Oct 20;282(15):1453-7
references.pmid: 10535436
references.citation: Lancet. 2013 Sep 7;382(9895):843
references.pmid: 24012258
references.citation: Obstet Gynecol Surv. 2008 Sep;63(9):585-96
references.pmid: 18713478
references.citation: Hypertens Res. 2011 Jan;34(1):62-9
references.pmid: 20927112
references.citation: Hypertens Res. 2008 Jun;31(6):1171-6
references.pmid: 18716365
references.citation: Lancet. 2009 Oct 10;374(9697):1226
references.pmid: 19819378
references.citation: Hypertension. 2012 Mar;59(3):580-6
references.pmid: 22232134
references.citation: Lancet. 2012 Apr 14;379(9824):e48
references.pmid: 22500880
references.citation: PLoS One. 2013 Jul 05;8(7):e66844
references.pmid: 23861749
references.citation: Eur Heart J. 2009 Oct;30(20):2461-9
references.pmid: 19723695
references.citation: JAMA Intern Med. 2013 Apr 8;173(7):580-1
references.pmid: 23440226